ZHONGSHENGYAOYE(002317.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
ZHONGSHENGYAOYE
002317.SZ
Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China. The company offers traditional Chinese medicine and chemical medicine. It also focuses on the fields of cardiovascular, respiratory, ophthalmology, and digestive.
2.788 T
002317.SZMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
C
PharmaceuticalsIndustry
Industry Ranking81/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE7.28%B
    • Profit Margin11.66%B
    • Gross Margin57.29%B
  • Growth ScoreC
    • Revenue YoY2.12%C
    • Net Profit YoY209.38%A
    • Total Assets YoY0.00%D
    • Net Assets YoY0.00%D
  • Cash ScoreC
    • Cash Flow Margin162.26%B
    • OCF YoY2.12%C
  • Operating ScoreE
    • Turnover0E
  • Debt ScoreA
    • Gearing Ratio0.00%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    In half a day, the main funds increased their positions in the pharmaceutical and biotechnology sector while selling off the electronics sector

    36Kr·
    SH
    600157
    -2.75%
    SZ
    000547
    -2.73%
    SZ
    002317
    +3.94%
    36Kr·
    SH
    600157
    -2.75%
    SZ
    000547
    -2.73%
    SZ
    002317
    +3.94%

    ZHONGSHENGYAOYE: Net profit in the third quarter was 62.6822 million yuan, a year-on-year increase of 2.10%

    Zhitong·
    SZ
    002317
    +3.94%
    Zhitong·
    SZ
    002317
    +3.94%

    ZHONGSHENGYAOYE: Subsidiary receives approval notice for the listing application of polyvinyl alcohol chemical raw materials

    Zhitong·
    SZ
    002317
    +3.94%
    Zhitong·
    SZ
    002317
    +3.94%

    ZHONGSHENGYAOYE's subsidiary has obtained ethical approval for the Phase III clinical trial of the innovative drug Anglatide granules

    Zhitong·
    SZ
    002317
    +3.94%
    Zhitong·
    SZ
    002317
    +3.94%

    ZHONGSHENGYAOYE released its performance for the first half of the year, with a net profit attributable to the parent company of 188 million yuan, a year-on-year increase of 114.96%

    Zhitong·
    SZ
    002317
    +3.94%
    Zhitong·
    SZ
    002317
    +3.94%
    © 2026 Longbridge｜Disclaimer